Eosinophils in chronic lung disease
Part of Lungs & breathing clinical trials.
This study looks at how eosinophils, a type of white blood cell, relate to chronic lung conditions. It tests whether higher eosinophil levels are linked to certain types of lung disease, without the influence of steroids or antifibrotic drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old
- You have a chronic lung condition (interstitial lung disease) diagnosed for more than 1 year
- You have a blood test result showing either high (over 300) or low (under 150) eosinophil levels
- You are not taking oral steroids or antifibrotic medications (pirfenidone or nintedanib)
- You are not pregnant, do not have certain other lung conditions, and do not have severe heart disease or need oxygen therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether things in your home might affect how quickly your lung disease gets worse. You and a matched group will be followed to see how your home environment impacts your lung health.
This study follows people with long-term high eosinophils (a type of white blood cell) and related conditions to learn how the illness changes over time. It helps doctors understand patterns of organ involvement and outcomes, which may improve future care.
This study collects information from people with various inflammatory lung conditions, like asthma or COPD, to better understand them and improve treatment. Healthy volunteers are also needed for comparison.
This study looks at how a type of white blood cell (eosinophil) works differently in people with eosinophilic lung diseases. It may help doctors understand these conditions better and find new treatments.
This research study examines how eosinophils (a type of white blood cell) behave and function when they become abnormally high in the blood or tissues. Researchers want to understand these conditions better to potentially improve treatment options.
This study looks at how certain immune cells (eosinophils) work in people with asthma. It compares people with mild to severe asthma, including those who have or haven't taken biologic treatments, against people without asthma. The goal is to better understand asthma and find new ways to treat it.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.